Xue Wang
Zhejiang Key Laboratory Of Pathophysiology
Ningbo, China
Ningbo, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Therapeutic options for different metastatic sites arising from renal cell carcinoma: A review.
Journal: Medicine
Published: May 24, 2024
SHC1 serves as a prognostic and immunological biomarker in clear cell renal cell carcinoma: a comprehensive bioinformatics and experimental analysis.
Journal: Scientific reports
Published: February 08, 2024
miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Journal: Oncology reports
Published: September 14, 2018
The antitumor activity of umbelliferone in human renal cell carcinoma via regulation of the p110γ catalytic subunit of PI3Kγ.
Journal: Acta pharmaceutica (Zagreb, Croatia)
Published: August 18, 2018
Ginkgetin induces apoptosis in 786-O cell line via suppression of JAK2-STAT3 pathway.
Journal: Iranian journal of basic medical sciences
Published: December 06, 2016
Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Journal: Molecular medicine reports
Published: October 14, 2016
Induction of cell cycle arrest by increasing GTP‑RhoA levels via Taxol‑induced microtubule polymerization in renal cell carcinoma.
Journal: Molecular medicine reports
Published: January 19, 2016
Decrease of phosphorylated proto-oncogene CREB at Ser 133 site inhibits growth and metastatic activity of renal cell cancer.
Journal: Expert opinion on therapeutic targets
Published: June 04, 2015
Cyclic AMP responsive element-binding protein promotes renal cell carcinoma proliferation probably via the expression of spindle and kinetochore-associated protein 2.
Journal: Oncotarget
Published: May 29, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026